- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Rheumatologic Disease
Total 379554 results
-
Vanda PharmaceuticalsUnknownRelapsed or Refractory Hematologic MalignanciesUnited States
-
Incyte CorporationCompletedSolid Tumors and Hematologic MalignancyUnited States
-
University Hospital, MontpellierRecruiting
-
Yonsei UniversityUnknownMalignant Hematologic DisorderKorea, Republic of
-
Children's Cancer Group, ChinaShanghai Pudong District Center for Disease Control and PreventionRecruitingHematologic Malignancy | Solid Tumor, Childhood | VaccinationChina
-
University of ChicagoCompletedLeukemia | Preleukemia | Advanced Hematologic MalignanciesUnited States
-
M.D. Anderson Cancer CenterTerminatedFatigue | Advanced Cancer | Hematologic MalignancyUnited States
-
Tarix PharmaceuticalsWithdrawnHematologic Malignancy | Cord Blood Transplant | Inherited Metabolic DiseaseUnited States
-
Dartmouth-Hitchcock Medical CenterRecruitingCancer | Hematologic Malignancy | Blood Cancer | Tumor, SolidUnited States
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Peking University People's Hospital; The First Affiliated Hospital of Zhengzhou... and other collaboratorsRecruitingCD7-positive Relapsed/Refractory Lymphoid Hematologic MalignanciesChina
-
Brigham and Women's HospitalHarvard Medical School (HMS and HSDM)CompletedHematopoietic/Lymphoid Cancer | Hematologic Malignancy | Blood CancerUnited States
-
M.D. Anderson Cancer CenterJazz PharmaceuticalsWithdrawn
-
Affiliated Hospital to Academy of Military Medical...Beijing JD Biotech Co. LTD.RecruitingAdult Relapsed/Refractory B-cell Hematologic MalignanciesChina
-
Sunshine Lake Pharma Co., Ltd.Active, not recruitingRelapsed or Refractory B-cell Hematologic MalignanciesChina
-
Constellation PharmaceuticalsNot yet recruitingSolid Tumor | Hematologic Malignancy | Advanced Malignancies
-
Beijing InnoCare Pharma Tech Co., Ltd.RecruitingAdvanced Solid Tumors and Hematologic MalignanciesChina
-
Suzhou Junjing BioSciences Co., Ltd.RecruitingAdvanced Solid Tumors | Advanced Hematologic MalignanciesChina
-
Ascentage Pharma Group Inc.RecruitingAdvanced Solid Tumors or Hematologic MalignanciesUnited States
-
Massachusetts General HospitalMedically HomeActive, not recruiting
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.TerminatedHematologic MalignancyChina
-
Massachusetts General HospitalActive, not recruitingHematologic Malignancy | CAR-T Cell TherapyUnited States
-
Scripps Translational Science InstituteCompleted
-
Imperial College Healthcare NHS TrustCompletedHematologic Malignancy | Graft Versus Host Disease | Allogeneic Stem Cell Transplant | Stem Cell Transplant Complications
-
Beckman Coulter, Inc.The First Affiliated Hospital with Nanjing Medical University; Tongji Hospital and other collaboratorsRecruitingHematologic Diseases | Hematologic Neoplasms | Hematologic MalignancyChina
-
University of RochesterRecruitingHematologic MalignanciesUnited States
-
Ascentage Pharma Group Inc.RecruitingHematologic MalignanciesUnited States, Australia
-
Julie-An M. TalanoMiltenyi Biotec, Inc.Active, not recruitingHematologic MalignanciesUnited States
-
Seoul National University HospitalMinistry of Health, Republic of Korea; The Korea Health Technology R&D Project...UnknownHematologic MalignanciesKorea, Republic of
-
Yale UniversityHospira, now a wholly owned subsidiary of PfizerCompleted
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedHematologic MalignanciesUnited States
-
Baylor College of MedicineThe Methodist Hospital Research InstituteTerminated
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedHematologic MalignanciesUnited States
-
University Hospital, CaenCompleted
-
He HuangCompletedHematologic MalignanciesChina
-
SecuraBioTerminatedHematologic MalignanciesUnited States
-
Dartmouth-Hitchcock Medical CenterCompletedHematologic MalignanciesUnited States
-
University Hospital, LimogesUnknown
-
M.D. Anderson Cancer CenterChiron CorporationCompletedHematologic MalignanciesUnited States
-
Fate TherapeuticsTerminatedA Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic MalignanciesHematologic MalignanciesUnited States
-
Dartmouth-Hitchcock Medical CenterTerminatedHematologic MalignanciesUnited States
-
Anne Beaven, MDNovartisWithdrawnHematologic MalignanciesUnited States
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR); The Ottawa Hospital; Hamilton... and other collaboratorsCompletedHematologic MalignanciesCanada
-
Abramson Cancer Center of the University of PennsylvaniaCompletedHematologic MalignanciesUnited States
-
Infinity Pharmaceuticals, Inc.Terminated
-
University Hospital TuebingenCompletedHematologic MalignanciesGermany
-
Genzyme, a Sanofi CompanyTerminatedHematologic MalignanciesUnited States
-
Emory UniversityCompletedHematologic MalignanciesUnited States
-
M.D. Anderson Cancer CenterCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedGraft vs Host Disease | Hematologic NeoplasmUnited States
-
A.O. Ospedale Papa Giovanni XXIIIAssociazione Italiana per la Ricerca sul CancroUnknown